Detection of Local Prostate Cancer Recurrence from PET/CT Scans Using Deep Learning.

IF 4.5 2区 医学 Q1 ONCOLOGY
Cancers Pub Date : 2025-05-06 DOI:10.3390/cancers17091575
Marko Korb, Hülya Efetürk, Tim Jedamzik, Philipp E Hartrampf, Aleksander Kosmala, Sebastian E Serfling, Robin Dirk, Kerstin Michalski, Andreas K Buck, Rudolf A Werner, Wiebke Schlötelburg, Markus J Ankenbrand
{"title":"Detection of Local Prostate Cancer Recurrence from PET/CT Scans Using Deep Learning.","authors":"Marko Korb, Hülya Efetürk, Tim Jedamzik, Philipp E Hartrampf, Aleksander Kosmala, Sebastian E Serfling, Robin Dirk, Kerstin Michalski, Andreas K Buck, Rudolf A Werner, Wiebke Schlötelburg, Markus J Ankenbrand","doi":"10.3390/cancers17091575","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Prostate cancer (PC) is a leading cause of cancer-related deaths in men worldwide. PSMA-directed positron emission tomography (PET) has shown promising results in detecting recurrent PC and metastasis, improving the accuracy of diagnosis and treatment planning. To evaluate an artificial intelligence (AI) model based on [<sup>18</sup>F]-prostate specific membrane antigen (PSMA)-1007 PET datasets for the detection of local recurrence in patients with prostate cancer. <b>Methods:</b> We retrospectively analyzed 1404 [<sup>18</sup>F]-PSMA-1007 PET/CTs from patients with histologically confirmed prostate cancer. Artificial neural networks were trained to recognize the presence of local recurrence based on the PET data. First, the hyperparameters were optimized for an initial model (model A). Subsequently, the bladder was localized using an already published model and a model (model B) was trained only on a 20 cm cube around the bladder. Finally, two separate models were trained on the same section depending on the prostatectomy status (model C (post-prostatectomy) and model D (non-operated)). <b>Results:</b> Model A achieved an accuracy of 56% on the validation data. By restricting the region to the area around the bladder, Model B achieved a validation accuracy of 71%. When validating the specialized models according to prostatectomy status, model C achieved an accuracy of 77% and model D an accuracy of 77%. All models achieved accuracies of almost 100% on the training data, indicating overfitting. <b>Conclusions:</b> For the presented task, 1404 examinations were insufficient to reach an accuracy of over 90% even when employing data augmentation, including additional metadata and performing automated hyperparameter optimization. The low F1-score and AUC values indicate that none of the presented models produce reliable results. However, we will facilitate future research and the development of better models by openly sharing our source code and all pre-trained models for transfer learning.</p>","PeriodicalId":9681,"journal":{"name":"Cancers","volume":"17 9","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12071661/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/cancers17091575","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Prostate cancer (PC) is a leading cause of cancer-related deaths in men worldwide. PSMA-directed positron emission tomography (PET) has shown promising results in detecting recurrent PC and metastasis, improving the accuracy of diagnosis and treatment planning. To evaluate an artificial intelligence (AI) model based on [18F]-prostate specific membrane antigen (PSMA)-1007 PET datasets for the detection of local recurrence in patients with prostate cancer. Methods: We retrospectively analyzed 1404 [18F]-PSMA-1007 PET/CTs from patients with histologically confirmed prostate cancer. Artificial neural networks were trained to recognize the presence of local recurrence based on the PET data. First, the hyperparameters were optimized for an initial model (model A). Subsequently, the bladder was localized using an already published model and a model (model B) was trained only on a 20 cm cube around the bladder. Finally, two separate models were trained on the same section depending on the prostatectomy status (model C (post-prostatectomy) and model D (non-operated)). Results: Model A achieved an accuracy of 56% on the validation data. By restricting the region to the area around the bladder, Model B achieved a validation accuracy of 71%. When validating the specialized models according to prostatectomy status, model C achieved an accuracy of 77% and model D an accuracy of 77%. All models achieved accuracies of almost 100% on the training data, indicating overfitting. Conclusions: For the presented task, 1404 examinations were insufficient to reach an accuracy of over 90% even when employing data augmentation, including additional metadata and performing automated hyperparameter optimization. The low F1-score and AUC values indicate that none of the presented models produce reliable results. However, we will facilitate future research and the development of better models by openly sharing our source code and all pre-trained models for transfer learning.

基于深度学习的PET/CT局部前列腺癌复发检测
背景:前列腺癌(PC)是全球男性癌症相关死亡的主要原因。psma定向正电子发射断层扫描(PET)在检测复发性PC和转移,提高诊断和治疗计划的准确性方面显示出良好的结果。评估基于[18F]-前列腺特异性膜抗原(PSMA)-1007 PET数据集的人工智能(AI)模型对前列腺癌患者局部复发的检测效果。方法:回顾性分析组织学证实的前列腺癌患者的1404 [18F]-PSMA-1007 PET/ ct。基于PET数据训练人工神经网络来识别局部复发的存在。首先,对初始模型(模型A)进行超参数优化。随后,使用已经发表的模型对膀胱进行定位,并且仅在膀胱周围20厘米的立方体上训练模型(模型B)。最后,根据前列腺切除术状态,在同一切片上训练两个单独的模型(模型C(前列腺切除术后)和模型D(未手术))。结果:A模型在验证数据上的准确率达到56%。通过将区域限制在膀胱周围区域,模型B的验证精度达到了71%。当根据前列腺切除术状态对专业模型进行验证时,模型C的准确率为77%,模型D的准确率为77%。所有模型对训练数据的准确率都接近100%,表明过拟合。结论:对于当前的任务,即使采用数据增强,包括额外的元数据和执行自动超参数优化,1404次检查也不足以达到90%以上的准确率。较低的f1得分和AUC值表明所提出的模型都不能产生可靠的结果。然而,我们将通过公开分享我们的源代码和所有用于迁移学习的预训练模型来促进未来的研究和开发更好的模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancers
Cancers Medicine-Oncology
CiteScore
8.00
自引率
9.60%
发文量
5371
审稿时长
18.07 days
期刊介绍: Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信